We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

63 hedge funds and large institutions have $15.6M invested in Seelos Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $791K | Put options by funds: $484K

7% less funds holding

Funds holding: 68 → 63 (-5)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

44% less capital invested

Capital invested by funds: $28M → $15.6M (-$12.4M)

75% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 16

Holders
63
Holders Change
-5
Holders Change %
-7.35%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
16
Closed
16
Calls
$791K
Puts
$484K
Net Calls
+$307K
Net Calls Change
-$230K

Top Buyers

Rank Fund Capital Flow
1
MWM
Modera Wealth Management
New Jersey
+$792K
2
SFWC
Strategic Family Wealth Counselors
New Jersey
+$94.2K
3
Mariner
Mariner
Kansas
+$48.8K
4
BAM
Belpointe Asset Management
Nevada
+$45.3K
5
VF
Virtu Financial
New York
+$31.4K

Top Sellers

Rank Fund Capital Flow
1
UIC
Uniplan Investment Counsel
Wisconsin
-$1.19M
2
Group One Trading
Group One Trading
Illinois
-$795K
3
WP
Woodline Partners
California
-$720K
4
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$478K
5
E
Ergoteles
New York
-$416K
Name Holding Trade Value Shares
Change 		Change in
Stake
Mariner
26
Mariner
Kansas
$36K +$48.8K +14 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$35.9K – – –
MFG
28
Merit Financial Group
Georgia
$34K – – –
BAM
29
Belpointe Asset Management
Nevada
$34K +$45.3K +13 New
SG Americas Securities
30
SG Americas Securities
New York
$31K -$6.97K -2 -14%
ETC
31
Exchange Traded Concepts
Oklahoma
$29K +$24.4K +7 +175%
HSBC Holdings
32
HSBC Holdings
United Kingdom
$28.4K -$38.4K -11 -50%
Charles Schwab
33
Charles Schwab
California
$26.6K – – –
VF
34
Virtu Financial
New York
$23K +$31.4K +9 New
Wells Fargo
35
Wells Fargo
California
$20.9K -$6.97K -2 -20%
CFG
36
Citizens Financial Group
Rhode Island
$20.7K – – –
FHC
37
First Heartland Consultants
Missouri
$20.6K – – –
Commonwealth Equity Services
38
Commonwealth Equity Services
Massachusetts
$19K – – –
CA
39
Crewe Advisors
Utah
$18.9K – – –
UBV
40
United Bank (Virginia)
Virginia
$17.8K – – –
Goldman Sachs
41
Goldman Sachs
New York
$14.3K -$3.49K -1 -17%
Stifel Financial
42
Stifel Financial
Missouri
$14K +$17.4K +5 New
HighTower Advisors
43
HighTower Advisors
Illinois
$14K -$10.5K -3 -33%
DFG
44
Delta Financial Group
New Jersey
$14K +$17.4K +5 New
Osaic Holdings
45
Osaic Holdings
Arizona
$13K – – –
VFA
46
Valeo Financial Advisors
Indiana
$10.3K – – –
RVPG
47
Relative Value Partners Group
$10.2K +$13.9K +4 New
First Manhattan
48
First Manhattan
New York
$9.62K – – –
Victory Capital Management
49
Victory Capital Management
Texas
$7.97K – – –
ACI
50
Alpha Cubed Investments
California
$7.47K – – –
1
2
3 4

SEEL Hedge Fund Activity: Q4 2022 in Review

63 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q4 2022, worth a combined $15.6M — down 44% from $28M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of SEEL and 11 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 4 added.

The largest buyer was Modera Wealth Management, opening a new position worth an estimated $792K. The largest seller was Uniplan Investment Counsel, cutting an estimated $1.19M.

  • 63 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q4 2022, down from 68 in Q3 2022.
  • Funds reported $15.6M of Seelos Therapeutics, Inc. Common Stock stock for Q4 2022, down 44% quarter-over-quarter.
  • 11 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q4 2022 and 16 closed out, a net change of -5 holders.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q4 2022 was Modera Wealth Management, an estimated $792K added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q4 2022 was Uniplan Investment Counsel, an estimated $1.19M sold.

Based on aggregated 13F filings for Q4 2022.